Clinical Trial

Doxycycline for Helicobacter Pylori Rescue Treatment

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2024 (before its estimated October 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
Current guidelines have recommended classical bismuth-containing quadruple therapy including proton-pump inhibitor, bismuth, tetracycline, metronidazole as the empirical rescue therapy. However, tetracycline is clinically unavailable in China and the high frequency of adverse events of bismuth quadruple therapy often result in poor compliance, which limited the applicability of this recommendation. This study aimed to compare the efficacy and tolerability of a 14-day bismuth-containing quadruple rescue therapy in which tetracycline was replaced by doxycycline.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-05-16; most recent amendment 2024-12-26.
Trial Details
NCT Number NCT05874570
Lead Sponsor Shanghai Jiao Tong University School of Medicine
Conditions Helicobacter Pylori Infection
Enrollment 368 participants
Start Date 2023-06-20
Primary Completion 2025-10-10 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-30